» Clinical Trials http://pharmaexecnews.com Fri, 29 Apr 2011 14:00:12 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 Researchers Gain More Insight on How Thalidomide Leads to Birth Defects http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/ http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/#comments Wed, 27 Apr 2011 08:00:07 +0000 admin http://pharmaexecnews.com/?p=11518 http://pharmaexecnews.com/biotechnology/researchers-gain-insight-thalidomide-leads-birth-defects/feed/ 0 Rate of Drug Approvals Dropping http://pharmaexecnews.com/biotechnology/rate-drug-approvals-dropping/ http://pharmaexecnews.com/biotechnology/rate-drug-approvals-dropping/#comments Thu, 17 Feb 2011 08:00:22 +0000 admin http://pharmaexecnews.com/?p=11173 http://pharmaexecnews.com/biotechnology/rate-drug-approvals-dropping/feed/ 0 Ariad Shares Soar after Cancer Drug Clears Late-stage Trial http://pharmaexecnews.com/pharmaceuticals/ariad-shares-soar-cancer-drug-clears-latestage-trial/ http://pharmaexecnews.com/pharmaceuticals/ariad-shares-soar-cancer-drug-clears-latestage-trial/#comments Wed, 26 Jan 2011 08:00:17 +0000 admin http://pharmaexecnews.com/?p=11107 http://pharmaexecnews.com/pharmaceuticals/ariad-shares-soar-cancer-drug-clears-latestage-trial/feed/ 0 Benlysta Review Spooks Investors http://pharmaexecnews.com/biotechnology/benlysta-review-spooks-investors/ http://pharmaexecnews.com/biotechnology/benlysta-review-spooks-investors/#comments Tue, 16 Nov 2010 08:00:06 +0000 admin http://pharmaexecnews.com/?p=10889 http://pharmaexecnews.com/biotechnology/benlysta-review-spooks-investors/feed/ 0 Potent New Hepatitis C Drug? http://pharmaexecnews.com/biotechnology/potent-hepatitis-drug/ http://pharmaexecnews.com/biotechnology/potent-hepatitis-drug/#comments Wed, 27 Oct 2010 08:00:06 +0000 admin http://pharmaexecnews.com/?p=10830 http://pharmaexecnews.com/biotechnology/potent-hepatitis-drug/feed/ 0 GSK, Theravance report promising PhII data for Advair successor http://pharmaexecnews.com/pharmaceuticals/gsk-theravance-report-promising-phii-data-advair-successor/ http://pharmaexecnews.com/pharmaceuticals/gsk-theravance-report-promising-phii-data-advair-successor/#comments Fri, 01 Oct 2010 08:00:53 +0000 admin http://pharmaexecnews.com/?p=10754 http://pharmaexecnews.com/pharmaceuticals/gsk-theravance-report-promising-phii-data-advair-successor/feed/ 0 Early-Stage Deals are Getting a Lot Sweeter for Biotechs http://pharmaexecnews.com/biotechnology/earlystage-deals-lot-sweeter-biotechs/ http://pharmaexecnews.com/biotechnology/earlystage-deals-lot-sweeter-biotechs/#comments Mon, 09 Aug 2010 08:00:53 +0000 admin http://pharmaexecnews.com/?p=10582 http://pharmaexecnews.com/biotechnology/earlystage-deals-lot-sweeter-biotechs/feed/ 0 Merck Buys Vax Unit from Bankrupt Hawaii Biotech http://pharmaexecnews.com/biotechnology/merck-buys-vax-unit-bankrupt-hawaii-biotech/ http://pharmaexecnews.com/biotechnology/merck-buys-vax-unit-bankrupt-hawaii-biotech/#comments Tue, 03 Aug 2010 08:00:24 +0000 admin http://pharmaexecnews.com/?p=10559 http://pharmaexecnews.com/biotechnology/merck-buys-vax-unit-bankrupt-hawaii-biotech/feed/ 0 Milestones Mitigate Risk in Biotech Deals http://pharmaexecnews.com/biotechnology/milestones-mitigate-risk-biotech-deals/ http://pharmaexecnews.com/biotechnology/milestones-mitigate-risk-biotech-deals/#comments Thu, 29 Jul 2010 08:00:23 +0000 admin http://pharmaexecnews.com/?p=10551 http://pharmaexecnews.com/biotechnology/milestones-mitigate-risk-biotech-deals/feed/ 0 Fastest Growing Therapeutic Classes (by Sales) http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/ http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/#comments Tue, 27 Jul 2010 08:00:34 +0000 admin http://pharmaexecnews.com/?p=10540 http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/feed/ 0